Skip to main content
ROSSARI BIOTECH LIMITED logo

ROSSARI BIOTECH LIMITED — Investor Relations & Filings

Ticker · ROSSARI ISIN · INE02A801020 LEI · 335800R7XFRR8ZTHBQ25 BSE.NS Manufacturing
Open in API
Filings indexed 529 across all filing types
Latest filing 2024-10-11 Regulatory Filings
Country IN India
Listing BSE.NS ROSSARI

About ROSSARI BIOTECH LIMITED

https://www.rossari.com/

Rossari Biotech Limited is a specialty chemicals manufacturer focused on providing sustainable and innovative solutions across diverse sectors. The company operates through three primary business segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals, and Animal Health and Nutrition. In the HPPC segment, it supplies essential ingredients for detergents, soaps, paints, and water treatment applications. Its textile division offers a comprehensive range of chemicals for the entire textile value chain, including pre-treatment, dyeing, and finishing processes. Additionally, the company provides high-quality feed additives and supplements for the poultry and livestock industries. Driven by robust research and development capabilities, Rossari Biotech emphasizes eco-friendly chemistry and customized formulations to meet specific client requirements. With advanced manufacturing facilities, the company serves a global clientele, maintaining a strong focus on operational excellence.

Recent filings

Filing Released Lang Actions
Board Meeting — ROSSARI BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 19-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for t…
Regulatory Filings
2024-10-11 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice dated October 11, 2024, informing about a forthcoming Board Meeting scheduled for October 19, 2024, to approve the unaudited financial results for the quarter and half year ended September 30, 2024. It references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulations 29 and 33, which pertain to disclosure of financial results. The document does not contain the financial results themselves but announces the upcoming approval and release of these results. The document length is 2110 characters, which is relatively short and consistent with an announcement rather than a full financial report. It also mentions the closure of the trading window around the announcement date, which is typical for such notices. Therefore, this document is an announcement of an upcoming financial report, not the report itself. According to the classification rules, such a document should be classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the timing of financial results, not the results themselves or a detailed report.
2024-10-11 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a compliance certificate related to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, concerning dematerialisation of shares and cancellation of share certificates for the quarter ended September 30, 2024. It is a confirmation letter from the Registrar and Transfer Agent to the company secretary, confirming compliance with regulatory requirements. The document is short (4128 characters) and primarily serves as a regulatory compliance confirmation rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is not an announcement of a report but a compliance certificate. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory compliance documents and confirmations that do not fit other specific categories.
2024-10-09 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is an intimation letter addressed to stock exchanges regarding the incorporation of a step-down wholly owned subsidiary, Rossari Biotech Trading FZE. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of a corporate event (incorporation of a subsidiary) rather than a financial report or detailed management discussion. It does not contain financial statements or detailed financial analysis. The document is a regulatory announcement about a corporate action, fitting the category of Capital/Financing Update (CAP) as it relates to changes in the company's capital structure through incorporation of a subsidiary. The document length is just over 5,000 characters but the content is clearly an announcement, not a full report. Therefore, the appropriate classification is CAP with high confidence.
2024-10-08 English
Agreements
Capital/Financing Update Classification · 95% confidence The document is an official communication dated September 28, 2024, addressed to stock exchanges (BSE Limited and National Stock Exchange of India Ltd.) regarding the allotment of a plot of land in Dahej, Gujarat. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events by listed companies. The content details the board's approval to purchase land for future expansion, including specifics about the agreement and parties involved. This is a regulatory announcement about a material event (land allotment) and not a financial report, earnings release, or management discussion. It is not a report publication announcement since it contains substantive information about the transaction. The document fits best under Capital/Financing Update (CAP) as it relates to a significant capital asset acquisition and board approval thereof, which impacts the company's capital structure and asset base.
2024-09-28 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notification about the closure of the trading window in compliance with insider trading regulations, specifically mentioning the period around the announcement of unaudited financial results for the quarter and half year ended September 30, 2024. It does not contain any financial data, results, or detailed report content. Instead, it is an announcement related to regulatory compliance and trading restrictions. The document length is short (1772 characters), and it serves as a formal notice rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and procedural announcements.
2024-09-26 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.